ALLISON HAYES: Open Payments
NPI 1154879674 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 25 payments from 9 companies in 2025. Trend: 2023 $223 · 2024 $39 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $176 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $78 |
| Tris Pharma Inc | 3 | $61 |
| Supernus Pharmaceuticals, Inc. | 2 | $49 |
| Corium, LLC | 3 | $45 |
| ABBVIE INC. | 1 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Bausch Health US, LLC | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: CAPLYTA, TRINTELLIX, Dyanavel XR, Qelbree, Azstarys, VRAYLAR, AUSTEDO XR, APLENZIN.
Industry payments across CT — which companies pay providers there.
